PBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Pitney Bowes Inc is not a strong buy for a beginner, long-term investor at this time. The company's financial performance is declining, analysts hold a negative outlook, and hedge funds are selling. While options data and technical indicators show some neutral to slightly positive trends, the overall sentiment and fundamentals do not support a buy decision.
The MACD is positive and expanding, indicating slight bullish momentum. RSI is neutral at 60.706, and moving averages are converging, showing no strong directional trend. Key support is at 10.35, and resistance is at 10.927. Pre-market price is down 1.19%, reflecting weak sentiment.
The stock is highlighted as a high dividend-yielding option, which may attract income-focused investors. Gross margin increased by 2.34% YoY in Q4 2025.
Analysts have an 'Underperform' rating with a price target below the current pre-market price. Hedge funds are selling heavily, with a 713.33% increase in selling activity last quarter.
In Q4 2025, revenue dropped to $477.6M (-7.46% YoY), net income fell to $27.3M (-173.15% YoY), and EPS decreased to $0.17 (-180.95% YoY). Gross margin improved slightly to 55.05% (+2.34% YoY), but overall financial performance is weak.
Analysts have a negative outlook on the stock. BofA recently raised the price target to $9.50 from $9 but maintained an 'Underperform' rating, citing risks from declining mailing volumes and flat earnings into 2026. Truist initiated coverage with a 'Hold' rating and an $11 price target, reflecting a cautious stance.
